Hormone replacement therapy and risk of endometrial cancer
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A.
Tumori 87(5): S20-S21
2001
ISSN/ISBN: 0300-8916 PMID: 11765201 Document Number: 529660
Document emailed within 1 workday
Related Documents
Matsushita, H.; Wakatsuki, A. 2012: Hormone replacement therapy and cancer risk Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 805-809Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Birch-Johansen, F.; Jensen, A.; Olesen, A.B.; Christensen, J.; Tjønneland, A.; Kjær, S.K. 2012: Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes and Control: Ccc 23(2): 379-388
Genazzani, A.; Gambacciani, M.; Simoncini, T.; Anniverno, R.; Becorpi, A.M.; Biglia, N.; Brandi, M.L.; Guaschino, S.; Lello, S.; Massobrio, M.; Melis, G.B.; Mencacci, C.; Modena, M.G.; Nappi, C.; Nappi, R.E.; Pecorelli, S.; Petraglia, F.; Rosano, G.M.; Serra, G.B.; Sismondi, P.; Taddei, S.; Tonelli, F. 2007: Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 23(8): 436-444
Brändstedt, J.; Wangefjord, S.; Nodin, Börn.; Eberhard, J.; Jirström, K.; Manjer, J. 2014: Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability Bmc Cancer 14: 371
Cook, L.S.; Dong, Y.; Round, P.; Huang, X.; Magliocco, A.M.; Friedenreich, C.M. 2014: Hormone contraception before the first birth and endometrial cancer risk Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 23(2): 356-361
Garnier, L.F.; Bourges, O. 2000: Vascular risk and menopause: role of hormone replacement therapy Presse Medicale 29(18): 1013-1018
Simon, T.; Jaillon, P. 2001: Hormone replacement therapy and cardiovascular risk in menopausal women Archives des Maladies du Coeur et des Vaisseaux 94(2): 132-138
Löfqvist, H.; Rylander, E. 2014: Hormone replacement therapy in menopause--risk of disreputable activities Lakartidningen 111(38): 1585
Baber, R.J.; Studd, J.W. 1989: Hormone replacement therapy and cancer British Journal of Hospital Medicine 41(2): 142; 144-146; 148-149
Yonei, Y.; Takahashi, Y.; Hibino, S. 2007: Hormone replacement Up-to-date. Hormone replacement therapy in anti-aging medicine Clinical Calcium 17(9): 1400-1406
1987: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257(6): 796-800
Collet, P. 2002: Hormone replacement therapy for menopause: continue or stop the prescription after 10 years? Should hormone replacement therapy be continued after 10 years? of course not! Gynecologie Obstetrique and Fertilite 30(9): 736-739
Arteaga-Gómez, A.C.; Castellanos-Barroso, G.; Colin-Valenzuela, A.; García-Vargas, J.; Márquez-Acosta, G.; Reyes-Muñoz, E. 2011: Hormone therapy effect in postmenopausal women with history of endometrial cancer Ginecologia y Obstetricia de Mexico 79(1): 11-17
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Audet-Lapointe, P.; Ayoub, J.; Methot, Y. 1988: An innovative protocol, cyclic hormone-chemotherapy in the treatment of high-risk localized endometrial cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 17(6): 751-755
Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17